2017 CSS Conference
 
Pharmacy Education Course - Agenda at a Glance
28/04/2017
8:00 am - 8:05 amWelcome and Introduction
8:05 am - 8:55 amScreening, Assessment and Diagnosis of Insomnia
8:55 am - 9:45 amTreatment of Insomnia
9:45 am - 10:05 amHealth Break and Exhibits Open
10:05 am - 10:55 amObstructive Sleep Apnea
10:55 am - 11:45 amCardiovascular Consequences of Obstructive Sleep Apnea
11:45 am - 12:45 pmLunch & Exhibits Open
12:45 pm - 1:35 pmBehavioral Therapy for Insomnia
1:35 pm - 2:25 pmCircadian Rhythm Disorders and Treatment Options
2:25 pm - 2:45 pmHealth Break and Exhibits Open
2:45 pm - 3:45 pmSleep Disorders Related to Menopause
8:00 am - 4:00 pmPharmacy Education Course
Pharmacy Education Course
Friday April 28, 2017
7:00 am - 7:00 pmRegistration Open
8:00 am - 4:00 pmPharmacy Education Course

This is a one-day continuing education event for pharmacists that aims to address their education needs in terms of the screening, assessment, management and therapeutic treatment of sleep.

Chronic insomnia is very prevalent in the community and will be reviewed in detail with pharmacist as the targeted audience. Given pharmacists’ expanded scope of practice in Alberta, the ability to understand, assess and manage sleep related disorders is critical. Screening, assessing and diagnosing insomnia will be introduced along with the latest TOP Insomnia Guidelines with cutting-edge treatment considerations and consequences of untreated insomnia. The benefits and risks associated with current drug therapies, such as benzodiazepines and non-benzodiazepines, will be discussed by experts in the field to provide pharmacists with the confidence to intervene and de-prescribe where appropriate. Cognitive Behavioral Therapy for Insomnia (CBT-i), a non-drug treatment option recommended as an initial intervention in sleep guidelines, will be discussed in detail and tailored towards how pharmacists can utilize such a program in practice to care for their patients. In addition, circadian sleep disorders will be reviewed and the evidence around current treatments for these disorders will be presented, including melatonin and light therapy. From a special populations perspective, insomnia related to menopause is prevalent and the screening and management of insomnia in women with menopause will be discussed in detail. The best local practices on screening and assessing for obstructive sleep apnea will be introduced, followed by treatment options and how pharmacists can refer, educate and monitor patients with this condition. The relationship of obstructive sleep apnea and cardiovascular disease will be discussed including the latest interventional SAVE study that challenges some of these concepts.

Program Learning Objectives:

  1. To be able to screen and assess patients presenting with the complaint of insomnia in the context of the potential consequences of the condition and to utilize tools that may be available to pharmacists.
  2. To be able to effectively manage drug therapy in the treatment of insomnia, understanding the risks and benefits related to different drug choices such as benzodiazepines, non-benzodiazepines and antihistamines.
  3. To be able to effectively communicate the importance and the proper conduct of a cognitive behavioral therapy program for insomnia.
  4. To be able to manage circadian sleep disorders utilizing available evidence of current drug and non-drug treatment options such as melatonin and light therapy.
  5. To be able to screen for and identify patients at risk of or experiencing obstructive sleep apnea and understand the treatment options available for this condition to refer, educate and monitor patients.
  6. To understand the cardiovascular consequences related to obstructive sleep apnea, the evidence related to this relationship, and how to manage patients at potential risk.

8:00 am - 8:05 amWelcome and Introduction
Chairperson: Candace Necyk MSc, BScPharm, Clinical Assistant Professor, Pharmacy and Pharmaceutical Sciences, University of Alberta
8:05 am - 8:55 amScreening, Assessment and Diagnosis of Insomnia
Speaker: Atul Khullar MD MSc FRCPC (Psychiatry) DABPN (Cert. Sleep Medicine), Medical Director, Northern Alberta Sleep Clinic
8:55 am - 9:45 amTreatment of Insomnia
Speaker: James MacFarlane Ph.D, D.ABSM, Assistant Professor of Pediatrics and Psychiatry, University of Toronto
9:45 am - 10:05 amHealth Break and Exhibits Open
10:05 am - 10:55 amObstructive Sleep Apnea
Speaker: Carol Chung MD FRCPC, Clinical lecturer. Department of Respirology and Sleep Medicine, University of Alberta

An overview of OSA will be provided. This talk aims at providing pharmacists with the basic knowledge of OSA that they may find relevant in their day to day practice. 

Learning Objectives

  1. Overview of OSA -  what it is and what are the risk factors
  2. Screening and diagnosis of OSA – tests available and evidence of screening
  3. Treatment options of OSA – pros/cons, efficiency of each

10:55 am - 11:45 amCardiovascular Consequences of Obstructive Sleep Apnea
Speaker: Owen Lyons MB BCh BAO, MRCPI, Respirologist and Sleep Physician, Women's College Hospital and University Health Network, Toronto, Assistant Professor, Division of Respirology, University of Toronto.
11:45 am - 12:45 pmLunch & Exhibits Open
12:45 pm - 1:35 pmBehavioral Therapy for Insomnia
Speaker: Tavis Campbell PhD. R.Psych., Professor, Department of Psychology, University of Calgary
1:35 pm - 2:25 pmCircadian Rhythm Disorders and Treatment Options
Speaker: Marie Dumont Ph.D. Neurosciences, Professor, Department of Psychiatry, University of Montreal

The physiological pathways underlying the effects of light exposure and melatonin on circadian rhythms will be described, and the general principles governing their effects will be reviewed. The characteristics of circadian sleep-wake disorders will be presented, as well as the symptoms of the most common circadian disorders including delayed sleep phase disorder, shift work and jet lag disorders, and the non-24 rhythm often observed in blind individuals. Recent research concerning the use of controlled light exposure and exogenous melatonin to help patients with circadian disorders will be presented. 

Learning Objectives

  1. To understand the mode of action of light therapy and exogenous melatonin on circadian rhythms.
  2. To know the main characteristics of circadian rhythms disorders.
  3. To learn current knowledge concerning the use of light therapy and melatonin in the management of circadian rhythm disorders.

2:25 pm - 2:45 pmHealth Break and Exhibits Open
2:45 pm - 3:45 pmSleep Disorders Related to Menopause
Speaker: Jerome W. Alonso MD, Medical Director, Canadian Sleep Consultants
3:45 pm - 4:00 pmClosing
Chairperson: Candace Necyk MSc, BScPharm, Clinical Assistant Professor, Pharmacy and Pharmaceutical Sciences, University of Alberta